JP2021527718A5 - - Google Patents

Info

Publication number
JP2021527718A5
JP2021527718A5 JP2021520455A JP2021520455A JP2021527718A5 JP 2021527718 A5 JP2021527718 A5 JP 2021527718A5 JP 2021520455 A JP2021520455 A JP 2021520455A JP 2021520455 A JP2021520455 A JP 2021520455A JP 2021527718 A5 JP2021527718 A5 JP 2021527718A5
Authority
JP
Japan
Prior art keywords
lactobacillus plantarum
nutritional supplement
pharmaceutical composition
probiotic strain
composition according
Prior art date
Application number
JP2021520455A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019243169A5 (https=
JP7476183B2 (ja
JP2021527718A (ja
Filing date
Publication date
Priority claimed from PCT/EP2018/066154 external-priority patent/WO2019242839A1/en
Application filed filed Critical
Publication of JP2021527718A publication Critical patent/JP2021527718A/ja
Publication of JPWO2019243169A5 publication Critical patent/JPWO2019243169A5/ja
Publication of JP2021527718A5 publication Critical patent/JP2021527718A5/ja
Application granted granted Critical
Publication of JP7476183B2 publication Critical patent/JP7476183B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021520455A 2018-06-18 2019-06-13 ラクトバチルス・プランタルムの組成物およびその使用 Active JP7476183B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2018/066154 WO2019242839A1 (en) 2018-06-18 2018-06-18 Lactobacillus plantarum compositions and uses thereof
EPPCT/EP2018/066154 2018-06-18
PCT/EP2019/065590 WO2019243169A1 (en) 2018-06-18 2019-06-13 Lactobacillus plantarum compositions and uses thereof

Publications (4)

Publication Number Publication Date
JP2021527718A JP2021527718A (ja) 2021-10-14
JPWO2019243169A5 JPWO2019243169A5 (https=) 2022-05-17
JP2021527718A5 true JP2021527718A5 (https=) 2022-05-17
JP7476183B2 JP7476183B2 (ja) 2024-04-30

Family

ID=62842054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021520455A Active JP7476183B2 (ja) 2018-06-18 2019-06-13 ラクトバチルス・プランタルムの組成物およびその使用

Country Status (12)

Country Link
US (1) US12558385B2 (https=)
EP (1) EP3806876B1 (https=)
JP (1) JP7476183B2 (https=)
KR (1) KR102770563B1 (https=)
CN (1) CN112638393B (https=)
AU (1) AU2018428571B2 (https=)
BR (1) BR112020026076A2 (https=)
CA (1) CA3102445A1 (https=)
ES (1) ES2966935T3 (https=)
MX (1) MX2020013860A (https=)
PL (1) PL3806876T3 (https=)
WO (2) WO2019242839A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3102445A1 (en) 2018-06-18 2019-12-26 Probi Ab Lactobacillus plantarum compositions and uses thereof
GB201908154D0 (en) * 2019-06-07 2019-07-24 Probi Ab Lactobacillus compositions and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1429802T3 (da) 2001-09-28 2013-02-18 Tntgamble Inc Tilførselssystem for biologisk komponent
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
SE527555C2 (sv) 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
ZA200802934B (en) * 2005-10-06 2009-09-30 Probi Ab Use of lactobacillus for treatment of virus infections
AU2006297896B2 (en) * 2005-10-06 2011-12-08 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
SE532899C2 (sv) * 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
SE533778C2 (sv) 2009-05-14 2011-01-11 Probi Ab Probiotisk fruktdryck
US10245290B2 (en) 2013-04-03 2019-04-02 Probi Ab Probiotic strains for use in treatment or prevention of osteoporosis
MX383492B (es) 2014-07-01 2025-03-04 Probi Usa Inc Comprimidos probióticos bicapa de doble liberación.
US20180289052A1 (en) 2015-10-07 2018-10-11 Bifodan A/S Probiotic formulation
GB201600975D0 (en) 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof
GB201708932D0 (en) 2017-06-05 2017-07-19 Probi Ab Microbial compositions
CA3102445A1 (en) 2018-06-18 2019-12-26 Probi Ab Lactobacillus plantarum compositions and uses thereof

Similar Documents

Publication Publication Date Title
JP7335246B2 (ja) 認知的及び精神的健康のためのプロバイオティクス
JP7523493B2 (ja) 情動的反応を制御するため、並びに潜在的な気分変調の治療及び予防のための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物
JP6444358B2 (ja) ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法
CN102076360B (zh) 益生菌、分泌型免疫球蛋白a和炎症
Rad et al. Might patients with immune-related diseases benefit from probiotics?
EP2308498A1 (en) Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
JP7366540B2 (ja) メタボリックシンドローム治療用栄養補助食品および食品組成物
AU2019359794B2 (en) Human dietary supplement and method for treating digestive system and immune-related disorders
JP7700109B2 (ja) 胃腸の健康組成物
JP2021527718A5 (https=)
JP6050341B2 (ja) 改善された食品組成物
CN107980002A (zh) 使用长双岐杆菌优化母乳喂养的方法和组合物
WO2023078603A1 (en) Oxytocin-mimetic compositions and uses thereof
Vijayaram et al. Probiotics: A multifaceted approach to health promotion-from disease prevention to food enrichment and delivery systems
US20250352589A1 (en) Oxytocin-mimetic compositions and uses thereof
JPWO2019243169A5 (https=)
CN116138457A (zh) 一种具有缓解抑郁样症状作用的复合营养组合物
US11020440B2 (en) Probiotic for the treatment of psoriasis
WO2026072929A1 (en) Compositions for treating gastrointestinal side effects of weight loss and diabetes medications
KOTWAL PROBIOTICS AND INFECTIOUS AGENTS BHARAT MENGI1, SK KOTWAL1 AND MANINDER SINGH1
Valmar AnMar Pharma
Calafiore et al. Gastroenterology and Hepatology Research